CAR T-cell therapy effective for refractory large B-cell lymphomas – medwireNews
|
CAR T-cell therapy effective for refractory large B-cell lymphomas
medwireNews medwireNews: The results of two studies published in The New England Journal of Medicine support the use of autologous chimeric antigen receptor (CAR) T cells directed against CD19 in patients with relapsed or refractory B-cell lymphomas. The first of … |
